Related Experiment Videos
[Lupus induced by quinidine]
P Tebas1, I Lozano, J de la Fuente
1Servicio de Medicina Interna II. Clínica Puerta de Hierro, Madrid.
Revista Clinica Espanola
|July 1, 1991
Summary
Quinidine can rarely cause drug-induced lupus erythematosus, a condition that may be overlooked. Early recognition and drug substitution are crucial for managing this rare adverse effect.
Area of Science:
- Rheumatology
- Clinical Pharmacology
- Drug Safety
Background:
- Drug-induced lupus erythematosus (DILE) is a rare condition.
- Quinidine is an antiarrhythmic medication with potential adverse effects.
- DILE can manifest with various clinical and analytical symptoms.
Observation:
- A case of a 34-year-old female patient who developed quinidine-induced lupus erythematosus (QI-SLE) is presented.
- The condition appeared 14 months after the initiation of quinidine therapy.
- Drug substitution was necessary due to the adverse effect.
Findings:
- Quinidine-induced lupus is a rare but significant adverse drug reaction.
- Diagnostic criteria for DILE are discussed in the context of QI-SLE.
- A review of 27 reported cases of QI-SLE highlights clinical and analytical manifestations.
Implications:
- Awareness of QI-SLE is essential for clinicians to avoid diagnostic delays.
- Prompt identification and discontinuation of quinidine can lead to lupus remission.
- Further research into the mechanisms and management of QI-SLE is warranted.